Showing results (371-380 of 945) with videos related to

Sort By:
Pageof 95
Journal of Hazardous Materials|January 2, 2013
Arsenite removal from aqueous solutions by γ-Fe2O3-TiO2 magnetic nanoparticles through simultaneous photocatalytic oxidation and adsorptionLian Yu, Xianjia Peng, Fan Ni, et al.
Immunology and Cell Biology|January 13, 2010
HDL and immunomodulation: an emerging role of HDL against atherosclerosisBi-lian Yu, Shu-hui Wang, Dao-quan Peng, et al.
International Immunopharmacology|June 27, 2021
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironmentLian Yu, Shuhui Cao, Jingwen Li, et al.
Frontiers in Nutrition|November 21, 2022
Selenium-containing polysaccharide from Spirulina platensis alleviates Cd-induced toxicity in mice by inhibiting liver inflammation mediated by gut microbiotaNing Zhou, Hairong Long, Lian Yu, et al.
Hematology (Amsterdam, Netherlands)|August 16, 2023
Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axisWeihao Wu, Jiayi Deng, Congjie Chen, et al.
Journal of Bioscience and Bioengineering|April 1, 2020
Rapid improvement in the macrolactins production of Bacillus sp. combining atmospheric room temperature plasma with the specific growth rate indexXiangxi Yi, Yuman Gan, Lei Jiang, et al.
Diabetes Care|December 31, 2008
Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adultsChien-Yu Lin, Pau-Chung Chen, Yu-Chuan Lin, et al.
The Journal of Physical Chemistry. B|April 16, 2011
Water self-diffusion in glassy and liquid maltose measured by Raman microscopy and NMRLei Zhu, Ting Cai, Jun Huang, et al.
Biochemical and Biophysical Research Communications|June 26, 2017
Apolipoprotein O expression in mouse liver enhances hepatic lipid accumulation by impairing mitochondrial functionFeng Tian, Chen-Lu Wu, Bi-Lian Yu, et al.
Translational Lung Cancer Research|June 16, 2023
Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort studyLian Yu, Jianlin Xu, Rong Qiao, et al.
Pageof 95